Quentis Therapeutics
Developing innovative immuno-therapeutics to combat ER stress and empower the immune system in the fight against cancer
est. 2016
Immatics is the older company (2000 vs 2016).
Side-by-Side Comparison
| Metric | Immatics | Quentis Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2000 older | 2016 |
| Headquarters | ||
| Headquarters | Germany | Not tracked yet |
| Employees | ||
| Employees | 637 | Not tracked yet |
| Industry | ||
| Industry | Not tracked yet | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | IPO | Grant |
| Total Funding | ||
| Total Funding | $908.10M | $49.00M |
| Funding Rounds | ||
| Funding Rounds | 14 | 2 |
| Services | ||
| Services | Precision targeting of PRAME in over 50 types of cancer, Development of cell therapies and bispecific products | Not tracked yet |
| Target Customers | ||
| Target Customers | Cancer patients with unmet medical needs, Healthcare professionals specializing in oncology, Research and academic institutions | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Precision Medicine, Cancer Immunotherapy, TCR T-cell Therapies, TCR Bispecifics, Adoptive Cell Therapy, PRAME Targeting, Solid Tumor Treatment, Peptidomics, Tumor-associated Peptides, Biopharmaceutical, Clinical Pipeline, HLA-restricted Target Discovery, Cancer Biomarkers, Bispecific Development, TCR Discovery | Immuno-therapeutics, ER Stress, Cancer Treatment, Immune System, Cancer Therapy, Innovative Treatments, Biopharmaceuticals, Oncology, Drug Development, Immunotherapy, Cancer Research |
| Website | ||
| Website | immatics.com | quentistx.com |
About Immatics
Immatics, founded in 2000 and headquartered in Germany, positions itself as a crucial player in the biotechnology sector. As the self-proclaimed "The Global Leader in Precision Targeting of PRAME", the company focuses on cancer treatment with a specialty in targeting PRAME—a protein expressed in ove...
About Quentis Therapeutics
Quentis Therapeutics is a biotechnology startup founded in 2016 that is focused on developing innovative immuno-therapeutics to combat ER stress and empower the immune system in the fight against cancer. The company's slogan, "Developing innovative immuno-therapeutics to combat ER stress and empower...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at Immatics and Quentis Therapeutics — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at Immatics and Quentis Therapeutics — by email.
Frequently Asked Questions
Compare Immatics with someone else
Start typing a company name or domain.